Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 1
1954 2
1955 3
1957 2
1958 2
1959 1
1960 2
1961 3
1962 4
1963 5
1964 4
1965 7
1966 19
1967 7
1968 10
1969 15
1970 18
1971 15
1972 14
1973 15
1974 22
1975 16
1976 14
1977 17
1978 25
1979 30
1980 39
1981 25
1982 33
1983 37
1984 32
1985 40
1986 58
1987 52
1988 42
1989 76
1990 93
1991 87
1992 96
1993 99
1994 130
1995 122
1996 100
1997 104
1998 110
1999 122
2000 141
2001 134
2002 113
2003 158
2004 156
2005 167
2006 153
2007 135
2008 164
2009 171
2010 181
2011 204
2012 202
2013 197
2014 228
2015 207
2016 202
2017 194
2018 235
2019 238
2020 262
2021 263
2022 250
2023 213
2024 227
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,065 results

Results by year

Filters applied: . Clear all
Page 1
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, Okumura N, Yamaguchi M, Ikeda N, Wakabayashi M, Nakamura K, Fukuda H, Nakamura S, Mitsudomi T, Watanabe SI, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Saji H, et al. Among authors: yamaguchi m. Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3. Lancet. 2022. PMID: 35461558 Clinical Trial.
Drosophila as a Model Organism.
Yamaguchi M, Yoshida H. Yamaguchi M, et al. Adv Exp Med Biol. 2018;1076:1-10. doi: 10.1007/978-981-13-0529-0_1. Adv Exp Med Biol. 2018. PMID: 29951811 Review.
Japanese guidelines for adult asthma 2020.
Nakamura Y, Tamaoki J, Nagase H, Yamaguchi M, Horiguchi T, Hozawa S, Ichinose M, Iwanaga T, Kondo R, Nagata M, Yokoyama A, Tohda Y; Japanese Society of Allergology. Nakamura Y, et al. Among authors: yamaguchi m. Allergol Int. 2020 Oct;69(4):519-548. doi: 10.1016/j.alit.2020.08.001. Epub 2020 Sep 4. Allergol Int. 2020. PMID: 32893125 Free article. Review.
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial.
Saura C, Oliveira M, Feng YH, Dai MS, Chen SW, Hurvitz SA, Kim SB, Moy B, Delaloge S, Gradishar W, Masuda N, Palacova M, Trudeau ME, Mattson J, Yap YS, Hou MF, De Laurentiis M, Yeh YM, Chang HT, Yau T, Wildiers H, Haley B, Fagnani D, Lu YS, Crown J, Lin J, Takahashi M, Takano T, Yamaguchi M, Fujii T, Yao B, Bebchuk J, Keyvanjah K, Bryce R, Brufsky A; NALA Investigators. Saura C, et al. Among authors: yamaguchi m. J Clin Oncol. 2020 Sep 20;38(27):3138-3149. doi: 10.1200/JCO.20.00147. Epub 2020 Jul 17. J Clin Oncol. 2020. PMID: 32678716 Free PMC article. Clinical Trial.
Exciting frontiers in drug hypersensitivity.
Yamaguchi M, Izuhara K. Yamaguchi M, et al. Allergol Int. 2019 Jul;68(3):287-288. doi: 10.1016/j.alit.2019.06.005. Allergol Int. 2019. PMID: 31266595 Free article. No abstract available.
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial.
Shiraishi Y, Nomura S, Sugawara S, Horinouchi H, Yoneshima Y, Hayashi H, Azuma K, Hara S, Niho S, Morita R, Yamaguchi M, Yokoyama T, Yoh K, Kurata T, Okamoto H, Okamoto M, Kijima T, Kasahara K, Fujiwara Y, Murakami S, Kanda S, Akamatsu H, Takemoto S, Kaneda H, Kozuki T, Ando M, Sekino Y, Fukuda H, Ohe Y, Okamoto I. Shiraishi Y, et al. Among authors: yamaguchi m. Lancet Respir Med. 2024 Nov;12(11):877-887. doi: 10.1016/S2213-2600(24)00185-1. Epub 2024 Aug 16. Lancet Respir Med. 2024. PMID: 39159638 Clinical Trial.
Role of Drosophila in Human Disease Research 3.0.
Cotterill S, Yamaguchi M. Cotterill S, et al. Among authors: yamaguchi m. Int J Mol Sci. 2023 Dec 25;25(1):292. doi: 10.3390/ijms25010292. Int J Mol Sci. 2023. PMID: 38203464 Free PMC article.
Japan's Ongoing Crisis on HPV Vaccination.
Sekine M, Kudo R, Yamaguchi M, Hanley SJB, Hara M, Adachi S, Ueda Y, Miyagi E, Ikeda S, Yagi A, Enomoto T. Sekine M, et al. Among authors: yamaguchi m. Vaccines (Basel). 2020 Jul 6;8(3):362. doi: 10.3390/vaccines8030362. Vaccines (Basel). 2020. PMID: 32640691 Free PMC article. Review.
In Vitro Analyses of Spinach-Derived Opioid Peptides, Rubiscolins: Receptor Selectivity and Intracellular Activities through G Protein- and β-Arrestin-Mediated Pathways.
Karasawa Y, Miyano K, Fujii H, Mizuguchi T, Kuroda Y, Nonaka M, Komatsu A, Ohshima K, Yamaguchi M, Yamaguchi K, Iseki M, Uezono Y, Hayashida M. Karasawa Y, et al. Among authors: yamaguchi m. Molecules. 2021 Oct 8;26(19):6079. doi: 10.3390/molecules26196079. Molecules. 2021. PMID: 34641621 Free PMC article.
6,065 results